Next Article in Journal
Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease
Next Article in Special Issue
The Therapeutic Potential of Neuronal K-Cl Co-Transporter KCC2 in Huntington’s Disease and Its Comorbidities
Previous Article in Journal
Selective Gold Recovery from Homogenous Aqueous Solutions Containing Gold and Platinum Ions by Aromatic Amino Acid-Containing Peptides
Previous Article in Special Issue
GABAA Receptor/STEP61 Signaling Pathway May Be Involved in Emulsified Isoflurane Anesthesia in Rats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Inter-Regulation of Kv4.3 and Voltage-Gated Sodium Channels Underlies Predisposition to Cardiac and Neuronal Channelopathies

1
Department of Cardiovascular Research, Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA
2
Division of Neurology, The Children’s Hospital of Philadelphia, Abramson Research Center, Room 512C-D, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA
3
Team “Genomics and Pathophysiology of Myocardial Diseases”, Faculté de Médecine Pitié-Salpêtrière, 91 Boulevard de l’Hôpital, Sorbonne Université, UMR_S1166, F-75013 Paris, France
4
Team “Genomics and Pathophysiology of Myocardial Diseases”, Faculté de Médecine Pitié-Salpêtrière, 91 Boulevard de l’Hôpital, INSERM, UMR_S1166, F-75013 Paris, France
5
Institute of Cardiometabolism and Nutrition, ICAN, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l’Hôpital, F-75013 Paris, France
6
Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
7
Lankenau Heart Institute, Main Line Health System, Wynnewood, PA 19096, USA
8
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19104, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(14), 5057; https://doi.org/10.3390/ijms21145057
Submission received: 10 June 2020 / Revised: 4 July 2020 / Accepted: 10 July 2020 / Published: 17 July 2020
(This article belongs to the Special Issue Ion Channel and Ion-Related Signaling 2020)

Abstract

:
Background: Genetic variants in voltage-gated sodium channels (Nav) encoded by SCNXA genes, responsible for INa, and Kv4.3 channels encoded by KCND3, responsible for the transient outward current (Ito), contribute to the manifestation of both Brugada syndrome (BrS) and spinocerebellar ataxia (SCA19/22). We examined the hypothesis that Kv4.3 and Nav variants regulate each other’s function, thus modulating INa/Ito balance in cardiomyocytes and INa/I(A) balance in neurons. Methods: Bicistronic and other constructs were used to express WT or variant Nav1.5 and Kv4.3 channels in HEK293 cells. INa and Ito were recorded. Results: SCN5A variants associated with BrS reduced INa, but increased Ito. Moreover, BrS and SCA19/22 KCND3 variants associated with a gain of function of Ito, significantly reduced INa, whereas the SCA19/22 KCND3 variants associated with a loss of function (LOF) of Ito significantly increased INa. Auxiliary subunits Navβ1, MiRP3 and KChIP2 also modulated INa/Ito balance. Co-immunoprecipitation and Duolink studies suggested that the two channels interact within the intracellular compartments and biotinylation showed that LOF SCN5A variants can increase Kv4.3 cell-surface expression. Conclusion: Nav and Kv4.3 channels modulate each other’s function via trafficking and gating mechanisms, which have important implications for improved understanding of these allelic cardiac and neuronal syndromes.

Graphical Abstract

1. Introduction

Variants in SCN5A, the gene encoding the cardiac voltage-gated sodium channel, Nav1.5, have been associated with life-threatening arrhythmia syndromes, including Brugada syndrome (BrS). BrS is an inherited cardiac channelopathy associated with a high risk of ventricular tachycardia and fibrillation leading to sudden cardiac death. The typical BrS electrocardiographic (ECG) pattern is characterized by the presence of prominent J waves appearing as ST-segment elevation, usually limited to the right precordial ECG leads, V1-V3 [1]. This ECG phenotype has been attributed to LOF variants in inward currents such as INa or to gain of function (GOF) variants in outward repolarizing currents such as Ito [2,3]. Interestingly, Portero et al. recently reported that expression of Kv4.3 can reduce INa [4]. A fine balance may thus exist between these two currents during the early phases of the action potential (AP). An increase in Ito associated with a GOF variants in Kv4.3, can simultaneously lead to LOF of INa. The reduced levels of INa affects the upstroke (phase 0) and in combination with augmented levels of Ito can accentuate phase 1 of the action potential and the phenotypic expression of BrS. Kv4.3 is also highly expressed in the brain and contributes to A-type current (IA) involved in the repolarization phase of the action potential of neurons. IA regulates subthreshold dendritic excitability and modulates dendritic calcium influx via voltage gated calcium channels in Purkinje cells. Kv4.3 LOF variants lead to repolarization defects and reduced cellular excitability, giving rise to spinocerebellar ataxia SCA19/22. Whereas LOF variants in KCND3 have been linked to SCA19/22, GOF variants have been associated with BrS. Interestingly, some KCND3 GOF variants (e.g., L450F) have been associated with both BrS and spinocerebellar ataxia SCA19/22 [5]. The reason for this dichotomy is not known and the ionic and cellular basis for SCA19/22 is not well defined. The present study examines the hypothesis that voltage-gated sodium (INa) and Kv4.3 (Ito) channels modulate each other’s function and that this inter-regulation is mediated by interaction of both α and β subunits forming a megacomplex or channelosome. To do so, we have selected well-characterized genetic variants that have been implicated in Brugada and/or spinocerebellar ataxia SCA19/22 syndromes. The non-conducting mutants R878C, G1743R and E555X of Nav1.5 respectively gating-deficient, trafficking-deficient and missense variant leading to a premature stop codon identified in BrS patients were selected. The GOF Kv4.3-L450F identified in BrS and SCA19/22 and the LOF Kv4.3-Δ227F associated with SCA19/22 were selected for study as well. In HEK293 cell line, we examined the effects of genetic variants in SCN5A associated with BrS on Kv4.3 function by examining the effect of Nav1.5 trafficking-deficient to Nav1.5 trafficking-efficient channels on Ito [2,3,6,7]. We then examined the effects of KCND3 variants associated with BrS and spinocerebellar ataxia SCA19/22, on both Nav1.5 and Nav1.1 function by examining the effect of Kv4.3 trafficking-deficient vs trafficking-efficient channels on INa. Finally, we examined regulation of the INa/Ito balance secondary to expression of the different auxiliary subunits, including: Navbeta1, MiRP3 and KCNIP2.

2. Results

2.1. R878C, G1743R and E555X Nav1.5 Variants Affect Ito

INa and Ito were recorded from HEK293 cells 36 h after co-transfection with pGFP-KCND3 and pGFP-SCN5A-WT, R878C or G1743R. None of the cells expressing the Nav1.5 variants displayed INa, (Supplementary Figure S1) consistent with previous reports by us and others showing that R878C and G1743R variants in SCN5A abolish INa [2,8,9,10]. It is noteworthy that we previously established that E555X mutation leads to expression of non-functioning truncated channels comprised of only the first domain [11]. Interestingly, in the cells expressing variant Nav1.5 channels, peak Ito was significantly increased when compared to cells expressing the WT Nav1.5 channel (Figure 1A,B and Table 1). The Nav1.5-R878C gating-deficient but trafficking efficient channel, in addition to abolishing INa due to major pore dysfunction was associated with the largest increase in Ito. These effects are consistent with the conditions known to give rise to the BrS phenotype. Interestingly, the Nav1.5-G1743R trafficking-deficient channel led to a significant 62.9% decrease of peak Ito, compared to Nav1.5-WT due to a −6.2 mV shift of steady-state inactivation (Figure 1A,C and Table 1). Indeed, the −40 mV prepulse used for the I-V curves in Figure 1B, represented by the vertical bar in Figure 1C, led to a greater inactivated fraction of Kv4.3 channels, 67.3% of WT explaining the decrease in Ito observed on the I-V curve (Figure 1B and Table 1). Ito recovery from inactivation was recorded but no significant difference was noted between WT and any of the SCN5A variant channels (Supplementary Figure S2).
In order to ascertain whether this effect could be due to the short isoform of KV4.3, another set of experiments was performed using pcDNA3.1-GFP-Nav1.5 and pGFP-Kv4.3-long isoform (Supplementary Figure S3). The effects observed on peak Ito were identical suggesting that these effects are independent of the isoform used.

2.2. LOF and GOF Variants of Kv4.3 Alter INa from Nav1.5 and Nav1.1

In another series of experiments, we sought to determine whether alterations in the expression of Kv4.3 channels can affect INa. We measured INa in cells expressing the LOF trafficking-deficient channel Δ227F-Kv4.3, the GOF trafficking efficient L450F-Kv4.3 and WT-Kv4.3. To avoid problems of transfection of multiple plasmids, we engineered a bicistronic construct, pKCND3-SCN5A. Thus, we co-transfected the pGFP-SCN1B with our WT or variant pKCND3-SCN5A bicistronic constructs. The positive green cells displaying the two currents therefore contained all three genes. Interestingly, even in presence of Navβ1, the trafficking-deficient Kv4.3-Δ227F significantly increased INa compared to WT and the GOF Kv4.3-L450F channel led to a significant decrease in INa when compared to WT and Kv4.3-Δ227F channels (Figure 2A,B; Supplementary Figure S4). Steady-state inactivation of INa was not significantly affected by the trafficking-efficient or -deficient Kv4.3 channels (Figure 2C). These results strongly support the hypothesis that the ability of Kv4.3 to traffic or not can regulate Nav1.5 function and likely its trafficking, even in the presence of Navβ1. In order to assess whether other voltage-gated sodium channel family members can be similarly affected, we performed experiments in a different model, in which we transfected WT or variant Kv4.3 channels into an HEK293 cell line stably expressing Nav1.1, Navβ1 and Navβ2. Very similar results were obtained; INa was significantly decreased in cells expressing the trafficking efficient Kv4.3-L450F channel and significantly increased in cells expressing the trafficking deficient Kv4.3-Δ227F channel compared to cells expressing the Kv4.3-WT channel. To exclude a potential effect of an overlap between INa and Ito, we designed a protocol allowing us to record INa free of the influence of Ito as explained in the Methods section. Under these conditions, Ito remains at the closed state, while INa recovers by 83.3 ± 0.02% (Supplementary Figure S5). Interestingly, we show that with Ito inactivated, INa recorded from cells expressing Kv4.3-L450F remains significantly reduced compared to those expressing Kv4.3-WT (Supplementary Figure S6). This control experiment excludes a potential overlap between inward and outward current as the cause of the significant decrease of INa in presence of a larger Ito.

2.3. Beta-Subunits of the Megacomplex Regulate the Balance between INa and Ito

To better understand how the interacting proteins of the megacomplex modulate the balance between INa and Ito, we co-expressed the bicistronic construct with several beta-subunits: Navβ1 encoded by SCN1B, MiRP3 encoded by KCNE4 or KChIP2 encoded by KCNIP2. Co-transfection of SCN1B with the bicistronic construct yielded an increase of INa and a significant decrease in Ito (Figure 3A; Supplement Figure S7: Raw traces of Nav1.5 + Kv4.3 in presence of β-subunits). Co-expression of MiRP3, which is known to reduce the trafficking of Kv4.3 channels and therefore Ito, significantly increased INa (Figure 3B; Supplementary Figure S7). Of note, in control experiments, the co-expression of MiRP3 with Nav1.5 in the absence of Kv4.3, did not modify INa (Figure 3C), while a drastic reduction of Ito was observed in cells expressing only Kv4.3, as expected (Figure 3D).
Similarly, when the bicistronic construct Kv4.3/Nav1.5 was expressed with KChIP2 the expected increase of Ito led to a drastic decrease in INa (Figure 4A; Supplementary Figure S7). In our control experiments co-expression of KChIP2 and Nav1.5, without Kv4.3 did not alter INa (Figure 4B). This result, once again strongly supports that the presence of Kv4.3 is required to modulate INa. In order to ensure that the presence of INa or Ito do not affect each other we calculated the significance of current density of INa at −40 mV (Ito~0) along with Ito at +45 mV (closest to INa reversal potential, INa~0). Surprisingly, we found that the beta-subunits, MiRP3 and Navβ1, which reduce Kv4.3 cell surface expression, increased INa. Moreover, KChIP2, which is known to increase Kv4.3 cell surface expression, drastically reduced INa (Figure 4A); Supplementary Figure S7). These findings provide compelling evidence in support of the hypothesis that changes in INa are mediated by the presence of Kv4.3 channels.

2.4. Nav1.5 and Kv4.3 Are Able to Interact

In order to determine whether the inter-regulation between Nav1.5 and Kv4.3 channels could be due to an interaction, we performed co-immunoprecipitation assays after co-transfection with tagged-channels (GFP-Nav1.5 and Kv4.3-Flag) in HEK293 cells. A positive signal for co-immunoprecipitation was observed for both Kv4.3 and Nav1.5 channels (Figure 5A and Supplementary Figure S8). It is noteworthy that Nav1.5-ΔCter (missing the cytoplasmic end of the protein) and Nav1.5-ΔNter (missing the cytoplasmic N-terminus) still co-immunoprecipitated with Kv4.3 (Figure 5A and Supplementary Figure S8). Moreover, no signal was detected when immunoprecipitation was performed using the anti-Flag antibody (specific to Kv4.3-Flag) on cell lysates expressing only Nav1.5 channel constructs as a negative control. This indicates that immunoprecipitation of Nav1.5 is conditioned and specific to the presence of Kv4.3. Taken together, these assays demonstrate that the two channels are able to interact without involvement of the Nav1.5 N- or C-termini. In order to further investigate a potential interaction in living cells, we performed the Duolink technique enabling the visualization of proteins in close proximity in situ. We observed that cells co-expressing both GFP-Nav1.5 and Kv4.3-Flag channels show robust positive red signals (Figure 5B). In contrast, cells co-expressing only GFP and Kv4.3-Flag, used as negative controls, did not display any red signal, discounting nonspecific interaction between GFP and the Kv4.3 channels. Moreover, this experiment allowed us to visualize that Nav1.5 and Kv4.3 reside in close proximity (<40 nm) at the membrane but also within intracellular compartments, supporting the hypothesis suggesting trafficking as one of the potential mechanisms regulating the INa/Ito balance.
Additionally, cell surface biotinylation revealed that the Nav1.5-R878C variant enhances cell surface expression of Kv4.3 channels (Figure 5C and Supplementary Figure S9), in agreement with our data showing an increase of Ito in the presence of the Nav1.5 variant (Figure 1). It is noteworthy that cell surface expression of Kv4.3 channels was not significantly different in the presence of the trafficking deficient G1743R-Nav1.5 compared to WT-Nav1.5 (Figure 5B). This result is also in agreement with our electrophysiology recordings showing that the 62.9% loss of peak Ito is due to the shift of the steady state inactivation in presence of the −40 mV prepulse. Indeed, in the protocol depicted in Figure 1, a prepulse at −40 mV was used to inactivate the WT sodium channel. This prepulse led to inactivation of a much larger portion of Kv4.3 channel in presence of Nav1.5-G1743R compared to Nav1.5-WT, as a result of the steady-state inactivation shift (Figure 1C). Indeed, at −40 mV, 49 ± 0.03% Kv4.3 channels are inactivated in presence of G1743R-Nav1.5 compared to WT-Nav1.5 consistent with the loss of function recorded in Figure 1A.

3. Discussion

The voltage-gated sodium channels Nav1.5, responsible for INa, play a crucial role in excitability and impulse propagation in the heart. Kv4.3 channels are responsible for Ito which gives rise to phase 1 of the cardiac AP. A fine balance between depolarization and repolarization during the early phase of the AP regulates action potential characteristics. An imbalance between the two currents, in particular a loss of function of INa and/or a gain of function in Ito, can importantly accentuate the AP notch leading to accentuation of the electrocardiographic J wave. Amplification of the J wave often appears as an ST segment elevation in the ECG and can predispose to the development of BrS and/or early repolarization syndrome, which comprise the J-wave syndrome [1,12,13,14,15]. Nav1.5 and Kv4.3 α-subunits have always been considered to be functionally independent. However, an increasing body of evidence points to the fact that voltage-gated ion channel α-subunits may not function completely independently of each other [2,10,11,16,17,18].The results described in the present study point to a fundamentally different model of sodium and potassium α-subunits interaction and function. We demonstrate that Nav1.5 and Kv4.3 α-subunits interact and inter-regulate each other’s function.
Our previous work has shown that voltage-gated sodium α-subunits are able to interact and form functional dimers mediated through recruitment of 14-3-3 proteins regulating the coupled gating of voltage-gated sodium channels responsible for the rapid upstroke of the AP in excitable tissues [2,10,11]. Thus, alteration of trafficking and gating of pathological channels can result in dominant-negative suppression leading to BrS [2,11,19]. We further showed that Nav1.1 and Nav1.2 are able to dimerize, which has far-reaching implications in neurological disorders including epilepsy or spinocerebellar ataxia [10,11,20]. Matamoros, et al. demonstrated that Kir2.1 and Nav1.5 α-subunits interact via α-syntrophin [17]. This interaction modulates the balance between IK1 and INa and supports the concept and importance of exploring the intricacies of megacomplex formation [17]. Their subsequent study demonstrated that Kir2.1 and Nav1.5 share a common pathway of trafficking to the cell surface, thus influencing cell excitability [18]. Consequently, disruption of Kir2.1 trafficking in cardiomyocytes affects trafficking of Nav1.5, which has important implications in the development of arrhythmias associated with inherited cardiac diseases. A recent study also reports interaction [2,11,19] between Kv4.3 and Kv11.1 (or hERG) proteins, leading to an increase in IKr current density when Kv11.1 and Kv4.3 are co-expressed [21]. Finally, Bilicki et al. have shown that a Kv7.1 trafficking-deficient variant impairs cell surface expression of Kv11.1 by physical interaction of the α-subunits responsible for IKr and IKs [22]. The list of auxiliary proteins interacting and regulating the trafficking and the gating of both Nav1.5 and Kv4.3 is ever-increasing. Navβ1 and SAP97 have previously been identified as important modulators. Recent work from Belau et al., demonstrated that DPP10 a previously known regulator of Kv4.3, also regulates the trafficking and gating of Nav1.5 [23]. At last, in support of our hypothesis, Portero et al. recently showed that an increased expression of Kv4.3 could lead to a decrease in INa [4].
In the present study, we investigated the potential for Nav1.5 variants to alter Ito and Kv4.3 variants to affect INa. We showed that contrary to traditional belief, Kv4.3 and Nav1.5 do not function independently and that they are able to inter-regulate each other, thus modulating their respective trafficking and gating. We were able to show that impairment of Kv4.3 trafficking, secondary to expression of KCNE4, leads to an increase of INa. In contrast, increased expression of KChIP2 produced an increase in Ito as well as a decrease in INa. A representation of this mechanism is schematically represented Figure 6. The J wave or ST segment elevation associated with BrS is known to be more prominent in the right ventricle (RV), accounting for the right ventricular nature of the syndrome. It has long been appreciated that this is due to the presence of a prominent AP notch in right versus left ventricle (LV), which in turn is due to the presence of a more prominent Ito in RV versus LV [24]. In support of our hypothesis, a recent study reported that, in addition to a more prominent Ito, RV displays a less prominent INa than LV, thus contributing to the appearance of a more prominent notch and J wave in RV [25].
Our study shows that SCN5A LOF variants can alter Ito by modulating Kv4.3 cell surface expression (R878C-Nav1.5) or by shifting its steady state inactivation (G1743R-Nav1.5). Reciprocally, the KCND3 GOF and LOF variants, L450F- and Δ227F-Kv4.3, are capable of decreasing and increasing INa from both Nav1.5 and Nav1.1 channels respectively, strongly suggesting that similar mechanisms of regulation are present in the heart and in the brain. We then sought to investigate whether the nonsense variant E555X could also alter Ito. Interestingly, the E555X variant was originally uncovered in a young child with BrS. Park et al. generated a pig model of this variant (E558X) in an attempt to recapitulate the Brugada phenotype in the pig [26]. Unlike in humans, in the pig this mutation led to cardiac conduction defect rather than BrS, with no hint of an ST-segment elevation or J wave in the ECG, even when challenged with the sodium channel blocker flecainide [26]. This was not surprising given that Kv4.3 is not expressed in the pig ventricle, which lacks Ito [1]. This finding, together with those reported by others [13,27,28] strongly support that the presence of a prominent Ito would lead to the expression of BrS/ERS as opposed to only cardiac conduction defect as a consequence of Nav1.5 LOF mutations. The present study provides further evidence in support of this hypothesis, demonstrating a significant increase in Ito by this nonsense mutation that causes total loss of INa. The effect of these genetic variants to produce reciprocal modulation of Kv4.3 and Nav1.5 ion channel activity leads to a synergistic shift in the balance of currents in the early phases of the RV epicardial action potential, thus accentuating the J wave or ST segment elevation in the ECG and the BrS phenotype. Inter-regulation of sodium channels with Kv4.3 pathogenic variants also provides new insights into factors contributing to potential mechanisms underlying the expression of spinocerebellar ataxia. Autosomal dominant cerebellar ataxias (SCAs) are progressive neurodegenerative disorders resulting from atrophy of the cerebellum leading to progressive ataxia of gait and limbs, as well as speech and eye movement difficulties [29]. Intriguingly, some SCAs and BrS possess striking similarities. They can be both associated with a loss of function of INa or a gain of function of Kv4.3 channels. Indeed, we previously demonstrated a key role for the N-terminus of Nav1.5 in channel trafficking [2], since variants in this region lead to retention of the variant in the endoplasmic reticulum and to BrS [2]. Likewise, Sharkey et al. reported a similar trafficking defect for Nav1.6 (SCN8A) N-terminal variants associated with ataxia [30]. These authors demonstrated that the channel is retained in the cis-Golgi resulting in reduced levels of Nav1.6 at the nodes of Ranvier in vivo. To date, 22 causal genes have been associated with spinocerebellar ataxia [29,31]. Twelve variants in KCND3 have been associated with spinocerebellar ataxia (SCA19/22). Ten of these variants have been shown to cause a LOF and two a GOF of IA [5,7,32,33,34,35,36,37]. However, the mechanism whereby Kv4.3 GOF mutation lead to SCA19/22 remain ununderstood. Interestingly, the two GOF variants, p.L450F and p.G600R located in the C-terminus of the channel have also been previously reported to be associated with BrS. Moreover, a missense variant in the C-terminus, p.R431C, was linked to episodic ataxia [38] and a de novo duplication of KCND3 was reported to cause early repolarization syndrome [39]. Furthermore, Takayama et al. recently reported the Kv4.3 GOF variant, p.G306A, to be responsible for early repolarization syndrome, refractory epilepsy, intellectual disability and paroxysmal atrial fibrillation [40]. Collectively, these studies provide further support for the hypothesis that GOF variants in KCND3 may share a common pathway to cardiac and neuronal channelopathies sometimes in the same patient.
The L450F variant of KCND3 studied in the present study has been associated with both BrS and SCA19/22 [3,41]. The L450F-Kv4.3 mediated GOF in Ito in the heart is consistent with the ionic mechanisms causing BrS. Although a similar GOF in I(A) was reported to cause spinocerebellar ataxia SCA19/22, the specific disease mechanism remains to be fully elucidated. Our findings suggest that the Kv4.3 GOF variants may give rise to ataxia due to a significant decrease of INa rather than an increase of I(A) [5]. This hypothesis remains to be more fully tested.
Until recently, studies of SCN5A or KCND3 variants have generally been approached with the traditional view that they are likely to exert an influence on INa or Ito, exclusively. Our findings highlight the need to expand our view of the megacomplex, also termed “the channelosome” to include association of Nav1.5 and Kv4.3 α-subunits regulating each other’s trafficking and gating. It is not yet known whether interaction between Nav1.5 and other potassium channels such as Kir2.X and Kv4.3 occurs in the same mega-complex and how their interaction impacts the dimerization of sodium channels. We could speculate that interactions between different α-subunits could also regulate the subcellular location of the channelosome, e.g., intercalated discs vs lateral membrane in cardiac myocytes or axon vs initial segment in neurons. Indeed, it was shown that distinct pools of Nav1.5 channels are directed either toward the lateral membrane as opposed to intercalated discs depending on whether they interact with α-syntrophin or SAP97 [42,43,44]. Our observations provide new insights into a wide range of cardiac and non-cardiac channelopathies, including epilepsy and spinocerebellar ataxia. The resulting paradigm shift is likely to open new perspectives for genetic screening of cardiac arrhythmia and other channelopathies caused by SCNXA or KCND3 variants. The knowledge gained may also be helpful in the design of novel approaches to therapy for these allelic syndromes.

4. Methods

4.1. cDNA Cloning and Mutagenesis

The following plasmids, all containing human channel subunit sequences, were used in this study: pcDNA3.1-GFP-SCN5A [2], pcDNA3.1-GFP-SCN5A-L1821fsX10 (= ΔCter), pGFP-N3-SCN5A-ΔNter generated by truncation of the 381 first nucleotides of SCN5A (127 amino acids), and replacement of residue 128 by a methionine (= ΔNter) [2], pGFP-poliovirus-SCN5A [11], pGFP-IRES-KCND3-Short and pCMV-KCND3-Long-FLAG. The bicistronic construct pKCND3-short-poliovirus-SCN5A plasmid was performed by Genscript (Piscataway, NJ, USA), SCN5A and KCND3 genes were subcloned and inserted into the pGFP-IRES plasmid by substituting GFP by KCND3-short. The pGFP-IRES-SCN1B, pDS-RED-IRES-KCNE4, pDS-RED-IRES, pGFP-IRES-KCNIP2 and pGFP-IRES were used to study the effect of the beta subunits with the bicistronic plasmid. Their coding sequences were CCDS844.1 for the-short isoform of KCND3 and CCDS843.1 for the long, CCDS 2456.2 for KCNE4, CCDS41562.1 for KCNIP2, and CCDS 46047.1 for SCN1B. Variants were prepared using the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies/Stratagene, Santa Clara, CA, USA) according to the manufacturer’s instructions and verified by sequencing.

4.2. HEK293 Cell Culture and Transfection

HEK293 cells were maintained in DMEM supplemented with 10% heat-inactivated fetal calf serum and 1% penicillin/streptomycin. For patch-clamp recordings, transfections were done with Polyfect transfection (Qiagen, Germantown, MD, USA) according to the manufacturer’s instructions and cells were transfected with the constructs of interest in 35-mm well dish, with a total of 0.6 µg of pCDNA3.1-GFP-SCN5A and 0.3 µg of KCND3 construct, molar ratio 2 to 1. Experiments using the bicistronic construct used 1.0 µg of bicistronic construct and 0.5 µg of the Beta IRES GFP subunit of interest in a ratio 2 to 1, per 35 mm dish. HEK293 Nav1.1, Navβ1, Navβ2 stable cell lines were a generous gift of Dr. Alfred George, Jr. from Northwestern University, Chicago, IL.
For co-immunoprecipitation experiments, cells were transfected with 1.5 µg of each channel plasmid per 25-cm2-culture flask using jetPEI (Polyplus Transfection, New York, NY, USA), except for negative controls using cells expressing only Nav1.5 constructs. All experimental data provided were performed with a minimum of 3 independent transfections; the n in electrophysiology figures represents the number of cells recorded.

4.3. Solutions for Electrophysiological Recordings

Thirty-six hours after transfection, HEK293 cells were trypsinized and seeded to a density that enabled single cells to be identified. Green positive cells were chosen for patch-clamp experiments. For patch clamp recordings, cells were bathed in an extracellular Tyrode’s solution containing in mM: 150 NaCl, 2 KCl, 1 MgCl2, 1.5 CaCl2, 1 NaH2PO4, 10 glucose, 10 HEPES, pH 7.4 (NaOH). Patch pipette medium was in mM: 125 KCl, 25 KOH, 1 CaCl2, 2 MgCl2, 4 K-ATP, 10 EGTA, 10 HEPES, adjusted to pH 7.2 with KOH. For INa recording only in Supplemental Data Figure S1, cells were bathed in an extracellular Tyrode solution containing in mM: 135 NaCl, 4 KCL, 2 MgCl2, 2.5 CaCl2, 1 NaH2PO4, 20 glucose, 10 HEPES, adjusted to pH 7.4 with NaOH. Patch pipette medium was in mM: 5 NaCl, 140 CsCl, 2 MgCl2, 4 Mg-ATP, 5 EGTA, 10 HEPES, adjusted to pH 4.2 with CsOH. For recording of Ito in Figure 3D, extracellular was in mM: 140 NaCl, 4 mM KCl, 2 CaCl2, 1 MgCl2, 5 HEPES, 10 Glucose, adjusted to pH 7.4 with NaOH. Intracellular solution was in mM: 125 KCl, 25 KOH, 1 CaCl2, 2 MgCl2, 4 K-ATP, 10 EGTA, 10 HEPES, adjusted to pH 7.2 with KOH.

4.4. Electrophysiological Recordings

Patch-clamp recordings were carried out in the whole-cell configuration at room temperature. Ionic currents were recorded with Axopatch 200B (Axon Instruments, San Jose, CA, USA) amplifier. Patch pipettes (Corning Kovar Sealing code 7052, WPI, Sarasota, FL, USA) had resistances of 1.2–2.5 MΩ in the whole cell configuration. Voltage errors were reduced via series resistance compensation below 5 mV. Currents were filtered at 5 kHz (−3 dB, 8-pole low-pass Bessel filter) and digitized at 30 kHz (NI PCI-6251, National Instruments, Austin, TX, USA). Data were acquired with pClamp 10 and analyzed with Clampfit (Axon Instruments, San Jose, CA, USA).
To measure peak INa or Ito amplitude and determine current-voltage relationships (I-V curves), currents were elicited by 500 ms-test potentials from −100 to +60 mV by increments of 5 mV from a holding potential of −120 mV. To record INa free of the influence of Ito, we inactivated Ito by introducing a 500 ms prepulse at 0 mV, which activates both channels. The test was introduced following a 10 ms inter-pulse interval at −120 mV. Because INa but not Ito recovers from inactivation during the 10 ms interval, INa can thus be recorded in the absence of Ito (Supplement Data Figure S6). For determination of steady-state inactivation of INa, a holding potential of −120 mV was used and a 500 ms conditioning prepulse was applied in 5 mV increments between −140 and −30 mV, followed by a 500-ms test pulse at −20 mV. For Ito steady-state inactivation the conditioning prepulses were performed between −120 mV and 0 mV, followed by a 500-ms test pulse at 40 mV.
Data for the activation-Vm and steady-state availability-Vm relationships of INa were fitted to the Boltzmann equation as described in Clatot et al. [11].

4.5. Co-Immunoprecipitation

Forty-eight hours after transfection with channel constructs, HEK293 cells were washed with phosphate buffer saline (PBS) and whole cell protein lysates were isolated using lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% Triton and protease inhibitor cocktail from Sigma-Aldrich, Saint Louis, MO, USA). Cell pellets were flushed 20 times through a 25-gauge needle, rotated for 1 h at 4 °C, and finally centrifuged for 30 min at 16,000× g. Dynabeads Protein G (Invitrogen, Waltham, MA, USA) washed twice with PBS-tween 0.02%, were, either used to pre-clear total proteins for 1 h at room temperature, or incubated with the anti-Flag antibody (Sigma-Aldrich, Saint Louis, MO, USA) for 2 h at room temperature, washed twice again with PBS-tween 0.02%, and incubated with the pre-cleared lysates. Samples were rotated overnight at 4 °C. After washing the beads 4 times with PBS-tween 0.02%, proteins were eluted with the Laemmli sample buffer at 37 °C for 30 min under agitation, separated on a NuPAGE 7% Tris-Acetate gel (Invitrogen), transferred to a nitrocellulose membrane and incubated with primary antibodies: mouse anti-Flag (1:500, Sigma-Aldrich), rabbit anti-Nav1.5 antibody (1:200, Alomone Labs, Jerusalem, Israel), and mouse anti-transferrin receptor (1:500, Invitrogen) as a loading control. Bound antibodies were detected using DyLight-conjugated secondary antibodies (Thermo-Fisher, Waltham, MA, USA), and protein signals were visualized using a Li-Cor Odyssey (Li-Cor Biosciences, Lincoln, NE, USA).

4.6. Duolink

The Duolink technique enables the detection and visualization of protein interactions in tissue and cell samples prepared for microscopy. Duolink detection was performed on HEK293 cell cultures fixed with methanol for 5 min at −20 °C. Cells were then washed twice for 5 min with PBS, blocked in PBS-5% BSA for 30 min at room temperature. Cells were incubated for 1 h with primary antibodies: rabbit anti-GFP (1:300, Torrey Pines Biolabs, Houston, TX, USA) against Nav1.5-GFP or GFP, mouse anti-Flag (1:300, Stratagene) against Kv4.3-Flag. The pair of oligonucleotide labeled secondary antibodies (PLA probes from Millipore Sigma, Burlington, MA, USA) was used following manufacturer’s instructions and imaging was performed using confocal microscope.

4.7. Cell Surface Biotinylation

Surface proteins of cells on 35-mm dishes were biotinylated using a cross-linking reagent (EZ-Link Sulfo-NHS-S-S-Biotin, Pierce Biotechnology, Rockford, IL, USA). HEK293 Cells were washed three times with ice-cold PBS-CM (PBS + 1 mM MgCl2 and 0.1 mM CaCl2), and 1 mg/mL of biotinylation reagent in 2.5 mL of biotinylation buffer (BB in mM: 150 NaCl, 2 CaCl2, and 10 triethanolamine) or buffer alone was added for 30 min on ice. After the cells were washed with quenching buffer (PBS-CM + 192 mM glycine and 25 mM Tris at pH7.5), whole cell protein lysates were isolated using Triton lysis buffer (in mM: 150 NaCl, 1.5 MgCl2, 20 HEPES, 1% Triton X-100, and 10% glycerol, pH 7.5) with protease and phosphatase inhibitors. Biotinylated proteins were recovered from the cell lysates with prewashed streptavidin-coated agarose beads (Sigma Chemical, Rockford, IL, USA). Proteins in the biotinylated (S = cell surface) and non-biotinylated (IC = intracellular fraction) fractions along with total lysates (TL) were separated by Western blot, transferred to PVDF membranes then probed with anti-Flag (1:1000) followed by anti-actin (1:1000) antibodies. Luminescence (Clarity, BioRad, Hercules, CA, USA) was detected using a ChemiDoc scanner (BioRad) and the Flag signal intensity in the TL and IC fractions were quantitated using Adobe Photoshop and normalized to actin signal intensity. IC intensity was calculated as a percentage of TL intensity and S abundance determined by subtraction of the latter from 100%.

4.8. Statistical Analysis

In order to test the primary hypothesis that there are significant differences between the control condition and each of the other conditions (e.g., presence of a variant or expression of beta-subunits), one-way or two-way analysis of variance (ANOVA) was used to conduct all analyses comparing control condition to each of the condition types individually with a Holm-Sidak correction, as appropriate (SigmaPlot® software). Results are presented as mean ± standard error (SEMs). Significance level p < 0.05 was considered significant.

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/21/14/5057/s1, Figure S1: Effect of Nav1.5 R878C and G1743R variants on INa, Figure S2: Recovery from inactivation of Kv4.3 in presence of SCN5A variants was not affected, Figure S3: Effect of Nav1.5 variants on Kv4.3-long, Figure S4: Raw traces of Nav1.5 WT + Nav 1 +Kv4.3-WT or variants, Figure S5: INa recovery from inactivation was not affected by Kv4.3 variants, Figure S6: Separating Ito from INa recordings to assess a potential overlap between the two currents, Figure S7: Raw traces of Nav1.5 + Kv4.3 in presence of -subunits, Figure S8: Co-IP full Blot, Figure S9: Cell surface biotinylation full blots.

Author Contributions

conceptualization, J.C.; methodology, J.C.; validation, J.C., N.N., R.C., J.H.; formal analysis, J.C., R.C., J.H.; investigation, J.C., N.N., R.C., C.S.; resources, P.G. and C.A.; data curation, J.C.; writing—original draft preparation, J.C.; writing—review and editing, J.C., P.G., N.N. and C.A.; visualization, J.C.; supervision, J.C., P.G., C.A.; funding acquisition, J.C., P.G., C.A. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a doctoral grant provided by the “CORDDIM” from the Region Ile de France (2009–2012) to J. Clatot (PI), NIH grants HL47678, HL138103 and HL152201 to C. Antzelevitch (C.A.), W.W. Smith Foundation Grant (C.A.) and the Wistar and Martha Morris Fund (C.A.).

Acknowledgments

We would like thank Alfred George, Jr. for the gift of the HEK293 Nav1.1, Navβ1, Navβ2 stable cell line.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

APAction Potential
BrSBrugada syndrome
NavSodium voltage-gated channels
INaInward sodium current
WTWild type
EREndoplasmic reticulum
Ito= IATransient outward potassium current
SCA19/22Spinocerebellar Ataxia type 19 and 22
LOFLoss of function
GOFGain of function

References

  1. Antzelevitch, C.; Yan, G.-X.; Ackerman, M.J.; Borggrefe, M.; Corrado, D.; Guo, J.; Gussak, I.; Hasdemir, C.; Horie, M.; Huikuri, H.; et al. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. J. Arrhythmia 2016, 32, 315–339. [Google Scholar] [CrossRef] [PubMed]
  2. Clatot, J.; Ziyadeh-Isleem, A.; Maugenre, S.; Denjoy, I.; Liu, H.; Dilanian, G.; Hatem, S.N.; Deschênes, I.; Coulombe, A.; Guicheney, P.; et al. Dominant-negative effect of SCN5A N-terminal mutations through the interaction of Nav1.5 α-subunits. Cardiovasc. Res. 2012, 96, 53–63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Giudicessi, J.R.; Ye, D.; Tester, D.J.; Crotti, L.; Mugione, A.; Nesterenko, V.V.; Albertson, R.M.; Antzelevitch, C.; Schwartz, P.J.; Ackerman, M.J. Transient outward current (Ito) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm 2011, 8, 1024–1032. [Google Scholar] [CrossRef] [Green Version]
  4. Portero, V.; Wilders, R.; Casini, S.; Charpentier, F.; Verkerk, A.O.; Remme, C.A. KV4.3 Expression Modulates NaV1.5 Sodium Current. Front. Physiol. 2018, 9, 178. [Google Scholar] [CrossRef] [PubMed]
  5. Duarri, A.; Nibbeling, E.; Fokkens, M.R.; Meijer, M.; Boddeke, E.; Lagrange, E.; Stevanin, G.; Brice, A.; Durr, A.; Verbeek, D.S. The L450F [Corrected] mutation in KCND3 brings spinocerebellar ataxia and Brugada syndrome closer together. Neurogenetics 2013, 14, 257–258. [Google Scholar] [CrossRef]
  6. Grant, A.O.; Carboni, M.P.; Neplioueva, V.; Starmer, C.F.; Memmi, M.; Napolitano, C.; Priori, S. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J. Clin. Invest. 2002, 110, 1201–1209. [Google Scholar] [CrossRef]
  7. Lee, Y.-C.; Durr, A.; Majczenko, K.; Huang, Y.-H.; Liu, Y.-C.; Lien, C.-C.; Tsai, P.-C.; Ichikawa, Y.; Goto, J.; Monin, M.-L.; et al. Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann. Neurol. 2012, 72, 859–869. [Google Scholar] [CrossRef] [Green Version]
  8. Valdivia, C. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs. Cardiovasc. Res. 2004, 62, 53–62. [Google Scholar] [CrossRef]
  9. Zhang, Y.; Wang, T.; Ma, A.; Zhou, X.; Gui, J.; Wan, H.; Shi, R.; Huang, C.; Grace, A.A.; Huang, C.L.-H.; et al. Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel. Acta Physiol. 2008, 194, 311–323. [Google Scholar] [CrossRef] [Green Version]
  10. Clatot, J.; Zheng, Y.; Girardeau, A.; Liu, H.; Laurita, K.R.; Marionneau, C.; Deschênes, I. Mutant voltage-gated Na+ channels can exert a dominant negative effect through coupled gating. Am. J. Physiol. Heart Circ. Physiol. 2018, 315, H1250–H1257. [Google Scholar] [CrossRef] [PubMed]
  11. Clatot, J.; Hoshi, M.; Wan, X.; Liu, H.; Jain, A.; Shinlapawittayatorn, K.; Marionneau, C.; Ficker, E.; Ha, T.; Deschênes, I. Voltage-gated sodium channels assemble and gate as dimers. Nat. Commun. 2017, 8, 2077. [Google Scholar] [CrossRef] [Green Version]
  12. Antzelevitch, C.; Patocskai, B. Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects. Curr. Probl. Cardiol. 2016, 41, 7–57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Antzelevitch, C.; Yan, G.-X. J-wave syndromes: Brugada and early repolarization syndromes. Heart Rhythm 2015, 12, 1852–1866. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Di Diego, J.M.; Antzelevitch, C. J wave syndromes as a cause of malignant cardiac arrhythmias. Pacing Clin. Electrophysiol. Pace 2018, 41, 684–699. [Google Scholar] [CrossRef] [PubMed]
  15. Haïssaguerre, M.; Derval, N.; Sacher, F.; Jesel, L.; Deisenhofer, I.; de Roy, L.; Pasquié, J.-L.; Nogami, A.; Babuty, D.; Yli-Mayry, S.; et al. Sudden cardiac arrest associated with early repolarization. N. Engl. J. Med. 2008, 358, 2016–2023. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Nof, E.; Vysochek, L.; Meisel, E.; Burashnikov, E.; Antzelevitch, C.; Clatot, J.; Beinart, R.; Luria, D.; Glikson, M.; Oz, S. Mutations in NaV1.5 Reveal Calcium-Calmodulin Regulation of Sodium Channel. Front. Physiol. 2019, 10, 700. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Matamoros, M.; Pérez-Hernández, M.; Guerrero-Serna, G.; Amorós, I.; Barana, A.; Núñez, M.; Ponce-Balbuena, D.; Sacristán, S.; Gómez, R.; Tamargo, J.; et al. Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels. Cardiovasc. Res. 2016, 110, 279–290. [Google Scholar] [CrossRef] [Green Version]
  18. Ponce-Balbuena, D.; Guerrero-Serna, G.; Valdivia, C.R.; Caballero, R.; Diez-Guerra, F.J.; Jiménez-Vázquez, E.N.; Ramírez, R.J.; Monteiro da Rocha, A.; Herron, T.J.; Campbell, K.F.; et al. Cardiac Kir2.1 and Nav 1.5 Channels Traffic Together to the Sarcolemma to Control Excitability. Circ. Res. 2018, 122, 1501–1516. [Google Scholar] [CrossRef]
  19. Keller, D.; Rougier, J.; Kucera, J.; Benammar, N.; Fressart, V.; Guicheney, P.; Madle, A.; Fromer, M.; Schlapfer, J.; Abriel, H. Brugada syndrome and fever: Genetic and molecular characterization of patients carrying mutations. Cardiovasc. Res. 2005, 67, 510–519. [Google Scholar] [CrossRef] [Green Version]
  20. Eijkelkamp, N.; Linley, J.E.; Baker, M.D.; Minett, M.S.; Cregg, R.; Werdehausen, R.; Rugiero, F.; Wood, J.N. Neurological perspectives on voltage-gated sodium channels. Brain 2012, 135, 2585–2612. [Google Scholar] [CrossRef]
  21. Zhao, X.-J.; Zhu, C.; Tian, L.-Y.; Fu, Y.-C.; Zhang, Y.; Chen, X.; Huang, Y.; Li, Y. Kv4.3 Modulates the Distribution of hERG. Sci. Rep. 2017, 7, 17757. [Google Scholar] [CrossRef] [Green Version]
  22. Biliczki, P.; Girmatsion, Z.; Brandes, R.P.; Harenkamp, S.; Pitard, B.; Charpentier, F.; Hébert, T.E.; Hohnloser, S.H.; Baró, I.; Nattel, S.; et al. Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: Evidence for clinically significant IKr-IKs α-subunit interaction. Heart Rhythm 2009, 6, 1792–1801. [Google Scholar] [CrossRef] [PubMed]
  23. Belau, F.; Metzner, K.; Christ, T.; Ravens, U.; Schaefer, M.; Künzel, S.; Li, W.; Wettwer, E.; Dobrev, D.; El-Armouche, A.; et al. DPP10 is a new regulator of Nav1.5 channels in human heart. Int. J. Cardiol. 2019, 284, 68–73. [Google Scholar] [CrossRef] [PubMed]
  24. Di Diego, J.M.; Sun, Z.Q.; Antzelevitch, C. I(to) and action potential notch are smaller in left vs. right canine ventricular epicardium. Am. J. Physiol. Heart Circ. Physiol. 1996, 271, H548–H561. [Google Scholar] [CrossRef] [PubMed]
  25. Calloe, K.; Aistrup, G.L.; Di Diego, J.M.; Goodrow, R.J.; Treat, J.A.; Cordeiro, J.M. Interventricular differences in sodium current and its potential role in Brugada syndrome. Physiol. Rep. 2018, 6, e13787. [Google Scholar] [CrossRef] [PubMed]
  26. Park, D.S.; Cerrone, M.; Morley, G.; Vasquez, C.; Fowler, S.; Liu, N.; Bernstein, S.A.; Liu, F.-Y.; Zhang, J.; Rogers, C.S.; et al. Genetically engineered SCN5A mutant pig hearts exhibit conduction defects and arrhythmias. J. Clin. Investig. 2015, 125, 403–412. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Szél, T.; Antzelevitch, C. Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome. J. Am. Coll. Cardiol. 2014, 63, 2037–2045. [Google Scholar] [CrossRef] [Green Version]
  28. Patocskai, B.; Antzelevitch, C. Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome. Expert Opin. Orphan Drugs 2015, 3, 633–651. [Google Scholar] [CrossRef] [Green Version]
  29. Durr, A. Autosomal dominant cerebellar ataxias: Polyglutamine expansions and beyond. Lancet Neurol. 2010, 9, 885–894. [Google Scholar] [CrossRef]
  30. Sharkey, L.M.; Cheng, X.; Drews, V.; Buchner, D.A.; Jones, J.M.; Justice, M.J.; Waxman, S.G.; Dib-Hajj, S.D.; Meisler, M.H. The ataxia3 Mutation in the N-Terminal Cytoplasmic Domain of Sodium Channel Nav1.6 Disrupts Intracellular Trafficking. J. Neurosci. 2009, 29, 2733–2741. [Google Scholar] [CrossRef] [Green Version]
  31. Sailer, A.; Houlden, H. Recent Advances in the Genetics of Cerebellar Ataxias. Curr. Neurol. Neurosci. Rep. 2012, 12, 227–236. [Google Scholar] [CrossRef] [PubMed]
  32. Duarri, A.; Jezierska, J.; Fokkens, M.; Meijer, M.; Schelhaas, H.J.; den Dunnen, W.F.A.; van Dijk, F.; Verschuuren-Bemelmans, C.; Hageman, G.; van de Vlies, P.; et al. Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19. Ann. Neurol. 2012, 72, 870–880. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Kurihara, M.; Ishiura, H.; Sasaki, T.; Otsuka, J.; Hayashi, T.; Terao, Y.; Matsukawa, T.; Mitsui, J.; Kaneko, J.; Nishiyama, K.; et al. Novel De Novo KCND3 Mutation in a Japanese Patient with Intellectual Disability, Cerebellar Ataxia, Myoclonus, and Dystonia. Cerebellum 2018, 17, 237–242. [Google Scholar] [CrossRef]
  34. Nibbeling, E.A.R.; Duarri, A.; Verschuuren-Bemelmans, C.C.; Fokkens, M.R.; Karjalainen, J.M.; Smeets, C.J.L.M.; de Boer-Bergsma, J.J.; van der Vries, G.; Dooijes, D.; Bampi, G.B.; et al. Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia. Brain 2017, 140, 2860–2878. [Google Scholar] [CrossRef] [PubMed]
  35. Smets, K.; Duarri, A.; Deconinck, T.; Ceulemans, B.; van de Warrenburg, B.P.; Züchner, S.; Gonzalez, M.A.; Schüle, R.; Synofzik, M.; Van der Aa, N.; et al. First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy. BMC Med. Genet. 2015, 16, 1–7. [Google Scholar] [CrossRef] [Green Version]
  36. Coutelier, M.; Coarelli, G.; Monin, M.-L.; Konop, J.; Davoine, C.-S.; Tesson, C.; Valter, R.; Anheim, M.; Behin, A.; Castelnovo, G.; et al. A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies. Brain 2017, 140, 1579–1594. [Google Scholar] [CrossRef]
  37. You, T.; Mao, W.; Cai, B.; Li, F.; Xu, H. Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function. Int. J. Mol. Med. 2015, 36, 309–315. [Google Scholar] [CrossRef] [Green Version]
  38. Choi, K.-D.; Kim, J.-S.; Kim, H.-J.; Jung, I.; Jeong, S.-H.; Lee, S.-H.; Kim, D.U.; Kim, S.-H.; Choi, S.Y.; Shin, J.-H.; et al. Genetic Variants Associated with Episodic Ataxia in Korea. Sci. Rep. 2017, 7, 13855. [Google Scholar] [CrossRef] [Green Version]
  39. Chauveau, S.; Janin, A.; Till, M.; Morel, E.; Chevalier, P.; Millat, G. Early repolarization syndrome caused by de novo duplication of KCND3 detected by next-generation sequencing. Heartrhythm Case Rep. 2017, 3, 574–578. [Google Scholar] [CrossRef] [Green Version]
  40. Takayama, K.; Ohno, S.; Ding, W.-G.; Ashihara, T.; Fukumoto, D.; Wada, Y.; Makiyama, T.; Kise, H.; Hoshiai, M.; Matsuura, H.; et al. A de novo gain-of-function KCND3 mutation in early repolarization syndrome. Heart Rhythm 2019, 16, 1698–1706. [Google Scholar] [CrossRef]
  41. Olesen, M.S.; Refsgaard, L.; Holst, A.G.; Larsen, A.P.; Grubb, S.; Haunsø, S.; Svendsen, J.H.; Olesen, S.-P.; Schmitt, N.; Calloe, K. A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation. Cardiovasc. Res. 2013, 98, 488–495. [Google Scholar] [CrossRef] [PubMed]
  42. Petitprez, S.; Zmoos, A.-F.; Ogrodnik, J.; Balse, E.; Raad, N.; El-Haou, S.; Albesa, M.; Bittihn, P.; Luther, S.; Lehnart, S.E.; et al. SAP97 and Dystrophin Macromolecular Complexes Determine Two Pools of Cardiac Sodium Channels Nav 1.5 in Cardiomyocytes. Circ. Res. 2011, 108, 294–304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Shy, D.; Gillet, L.; Abriel, H. Targeting the Sodium Channel NaV 1.5 to Specific Membrane Compartments of Cardiac Cells: Not a Simple Task! Circ. Res. 2014, 115, 901–903. [Google Scholar] [CrossRef] [Green Version]
  44. Rougier, J.-S.; Essers, M.C.; Gillet, L.; Guichard, S.; Sonntag, S.; Shmerling, D.; Abriel, H. A Distinct Pool of Nav1.5 Channels at the Lateral Membrane of Murine Ventricular Cardiomyocytes. Front. Physiol. 2019, 10, 834. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. The presence of Nav1.5 variants affects outward current (Ito). (A) Ito current–voltage relationships recorded from HEK293 cells co-expressing Kv4.3-short (pGFP-IRES-KCND3-Short) channels and either WT, R878C, G1743R, or E555X-Nav1.5 channels (pcDNA3.1-GFP-SCN5A). (B): Representative current traces of INa in the prepulse followed by Ito. Inset shows the voltage protocol employed. The presence of Nav1.5 variants significantly affect Ito compared to WT, at + 20 mV, *** p < 0.001 for the three variants (In pA/pF; WT = 87.14 ± 8.2, R878C = 243.3 ± 57.55, G1743R = 54.8 ± 12.9, E555X = 138 ± 16.8) (C): Ito steady-state inactivation. Note: G1743R-Nav1.5 significantly shifts the steady-state inactivation V1/2 of Ito compared to WT-Nav1.5, *** p < 0.001. n represents the number of recorded cells. In panel A, n = 50 WT cells correspond to total of WT cells patched against each variant.
Figure 1. The presence of Nav1.5 variants affects outward current (Ito). (A) Ito current–voltage relationships recorded from HEK293 cells co-expressing Kv4.3-short (pGFP-IRES-KCND3-Short) channels and either WT, R878C, G1743R, or E555X-Nav1.5 channels (pcDNA3.1-GFP-SCN5A). (B): Representative current traces of INa in the prepulse followed by Ito. Inset shows the voltage protocol employed. The presence of Nav1.5 variants significantly affect Ito compared to WT, at + 20 mV, *** p < 0.001 for the three variants (In pA/pF; WT = 87.14 ± 8.2, R878C = 243.3 ± 57.55, G1743R = 54.8 ± 12.9, E555X = 138 ± 16.8) (C): Ito steady-state inactivation. Note: G1743R-Nav1.5 significantly shifts the steady-state inactivation V1/2 of Ito compared to WT-Nav1.5, *** p < 0.001. n represents the number of recorded cells. In panel A, n = 50 WT cells correspond to total of WT cells patched against each variant.
Ijms 21 05057 g001
Figure 2. KV4.3 variants affect INa. (A): Representative traces of Ito and INa measured in HEK293 cells co-expressing the bicistronic construct Nav1.5/Kv4.3-WT, -Δ227F or -L450F (pKCND3-Short-poliovirus-SCN5A) with Navβ1/GFP reporter gene (pGFP-IRES-SCN1B). (B): Normalized current–voltage relationships, the trafficking-efficient L450F leads to an increase of Ito and a significant decrease in INa at potentials positive to −35 mV p = 0.039 (p < 0.001 at −20 mV), whereas the trafficking-deficient Δ227F-Kv4.3 leads to a decrease of Ito but a significant increase in INa at potentials positive to −45 mV p = 0.018 (p < 0.001 at −20 mV). (C): Steady state inactivation of INa. Kv4.3 variants did not affect INa steady-state inactivation. (D): Normalized current–voltage relationship in HEK293 cells stably expressing Nav1.1, Navβ1 and Navβ2 and transfected with Kv4.3-S WT vs mutants (pGFP-IRES-KCND3-short). The trafficking-efficient L450F leads to an increase of Ito but a significant decrease in INa at potentials positive to −30 mV p = 0.04 (p < 0.001 at −5 mV), whereas the trafficking-deficient Δ227F-Kv4.3 leads to a decrease of Ito but a significant increase in INa at potentials positive to −20 mV p = 0.05 (p < 0.001 at −5 mV). Note: n represents the number of cells recorded.
Figure 2. KV4.3 variants affect INa. (A): Representative traces of Ito and INa measured in HEK293 cells co-expressing the bicistronic construct Nav1.5/Kv4.3-WT, -Δ227F or -L450F (pKCND3-Short-poliovirus-SCN5A) with Navβ1/GFP reporter gene (pGFP-IRES-SCN1B). (B): Normalized current–voltage relationships, the trafficking-efficient L450F leads to an increase of Ito and a significant decrease in INa at potentials positive to −35 mV p = 0.039 (p < 0.001 at −20 mV), whereas the trafficking-deficient Δ227F-Kv4.3 leads to a decrease of Ito but a significant increase in INa at potentials positive to −45 mV p = 0.018 (p < 0.001 at −20 mV). (C): Steady state inactivation of INa. Kv4.3 variants did not affect INa steady-state inactivation. (D): Normalized current–voltage relationship in HEK293 cells stably expressing Nav1.1, Navβ1 and Navβ2 and transfected with Kv4.3-S WT vs mutants (pGFP-IRES-KCND3-short). The trafficking-efficient L450F leads to an increase of Ito but a significant decrease in INa at potentials positive to −30 mV p = 0.04 (p < 0.001 at −5 mV), whereas the trafficking-deficient Δ227F-Kv4.3 leads to a decrease of Ito but a significant increase in INa at potentials positive to −20 mV p = 0.05 (p < 0.001 at −5 mV). Note: n represents the number of cells recorded.
Ijms 21 05057 g002
Figure 3. Navβ1 and MiRP3 decrease Ito and increase INa. HEK293 cells were transfected with the bicistronic construct Nav1.5/Kv4.3 (pKCND3-Short-poliovirus-SCN5A), with or without NaVβ1 (pGFP-IRES-SCN1B vs pGFP) or MiRP3 (pRFP-IRES-KCNE4 vs pRFP) (A,B), or with Nav1.5 (pcDNA3.1-GFP-SCN5A)(C), or Kv4.3 (pGFP-IRES-KCND3-Short)(D) with MiRP3. (A): Current–voltage relationship measured in HEK293 cells co-expressing the bicistronic construct Nav1.5/Kv4.3 (pKCND3-Short-poliovirus-SCN5A), with or without NaVβ1 (pGFP-IRES-SCN1B vs pGFP) showing significant INa increase in presence of Navβ1 at potentials positive to −45 mV p < 0.001 (p < 0.001 at −20 mV) and Ito decrease in presence of Navβ1 at potentials positive to −5 mV p = 0.049 (p < 0.001 at +40 mV) (B): INa increases significantly in presence of MiRP3 at potentials positive to −45 mV p < 0.001 (p < 0.001 at −40 mV) while Ito decreases significantly at potentials positive to −10 mV p = 0.039 (p < 0.001 at +40 mV). (C): In absence of Kv4.3, MiRP3 has no effect on INa. (D): In absence of Nav1.5, MiRP3 decrease Ito at potentials positive to −20 mV p < 0.001 (p < 0.001 at +40 mV) Note: β-subunits that decrease Ito lead to a significant increase of INa only if both channels, Nav1.5 and Kv4.3, are present. n represents the number of cells recorded.
Figure 3. Navβ1 and MiRP3 decrease Ito and increase INa. HEK293 cells were transfected with the bicistronic construct Nav1.5/Kv4.3 (pKCND3-Short-poliovirus-SCN5A), with or without NaVβ1 (pGFP-IRES-SCN1B vs pGFP) or MiRP3 (pRFP-IRES-KCNE4 vs pRFP) (A,B), or with Nav1.5 (pcDNA3.1-GFP-SCN5A)(C), or Kv4.3 (pGFP-IRES-KCND3-Short)(D) with MiRP3. (A): Current–voltage relationship measured in HEK293 cells co-expressing the bicistronic construct Nav1.5/Kv4.3 (pKCND3-Short-poliovirus-SCN5A), with or without NaVβ1 (pGFP-IRES-SCN1B vs pGFP) showing significant INa increase in presence of Navβ1 at potentials positive to −45 mV p < 0.001 (p < 0.001 at −20 mV) and Ito decrease in presence of Navβ1 at potentials positive to −5 mV p = 0.049 (p < 0.001 at +40 mV) (B): INa increases significantly in presence of MiRP3 at potentials positive to −45 mV p < 0.001 (p < 0.001 at −40 mV) while Ito decreases significantly at potentials positive to −10 mV p = 0.039 (p < 0.001 at +40 mV). (C): In absence of Kv4.3, MiRP3 has no effect on INa. (D): In absence of Nav1.5, MiRP3 decrease Ito at potentials positive to −20 mV p < 0.001 (p < 0.001 at +40 mV) Note: β-subunits that decrease Ito lead to a significant increase of INa only if both channels, Nav1.5 and Kv4.3, are present. n represents the number of cells recorded.
Ijms 21 05057 g003
Figure 4. KChIP2 known to increase Ito decrease INa. HEK293 cells were transfected with either the bicistronic construct Nav1.5/Kv4.3 (pKCND3-Short-poliovirus-SCN5A) (A, C), or with Nav1.5 (pGFP-SCN5A) (B), with or without KChIP2 (pGFP-KCNIP2 vs pGFP), Navβ1 (pGFP-IRES-SCN1B vs pGFP), or MiRP3 (pRFP-IRES-KCNE4 vs pRFP). (A): Current–voltage relationships show that INa is significantly decreased in the presence of KChIP2 at potentials positive to −45 mV p = 0.024 (p = 0.002 at −40 mV), whereas Ito is significantly increased at potentials positive to −40 mV p = 0.009 (p < 0.001 at +45 mV). (B): In absence of Kv4.3, KChIP2 has no effect on INa. n represents the number of cells recorded.
Figure 4. KChIP2 known to increase Ito decrease INa. HEK293 cells were transfected with either the bicistronic construct Nav1.5/Kv4.3 (pKCND3-Short-poliovirus-SCN5A) (A, C), or with Nav1.5 (pGFP-SCN5A) (B), with or without KChIP2 (pGFP-KCNIP2 vs pGFP), Navβ1 (pGFP-IRES-SCN1B vs pGFP), or MiRP3 (pRFP-IRES-KCNE4 vs pRFP). (A): Current–voltage relationships show that INa is significantly decreased in the presence of KChIP2 at potentials positive to −45 mV p = 0.024 (p = 0.002 at −40 mV), whereas Ito is significantly increased at potentials positive to −40 mV p = 0.009 (p < 0.001 at +45 mV). (B): In absence of Kv4.3, KChIP2 has no effect on INa. n represents the number of cells recorded.
Ijms 21 05057 g004
Figure 5. Nav1.5 and Kv4.3 interact with each other. (A): Co-immunoprecipitation between Nav1.5 and Kv4.3. HEK293 cells were transfected with WT or truncated Nav1.5 constructs and Kv4.3 (pcDNA3.1-GFP-SCN5A and pCMV-KCND3-Long-Flag) as indicated above the lanes. The total cell lysates were immunoprecipitated with an anti-Flag antibody, specific to Kv4.3-Flag, cross-linked to beads. The blots were hybridized with an anti-Nav1.5 antibody (top gels: Blot Ab: Nav1.5) or an anti-Flag antibody (bottom gels: Blot Ab: Flag). The left side corresponds to the total cell lysates of transfected cells before IP. The right side (IP with Flag Ab) corresponds to the elution fractions from beads. The negative control (center of panel A), consisting in an anti-Flag immunoprecipitation in lysates of cells expressing only GFP-Nav1.5 channels, clearly excluded any non-specific interaction between Nav1.5 and Kv4.3 channels. The results demonstrated an interaction between Kv4.3 and Nav1.5 (n = 7). (B): Duolink between GFP-Nav1.5 and Kv4.3-Flag. The top line corresponds to cells co-expressing GFP alone (pGFP) with Kv4.3-Flag while the bottom line cells co-expressing GFP-Nav1.5 with Kv4.3-Flag. Only cells expressing GFP-Nav1.5 and Kv4.3-Flag display red positive signals indicating a close proximity between the two channels. Note: Close proximity of the two channels can be observed within intracellular compartments. (C): Cell surface biotinylation of Kv4.3 in presence of WT, R878C or G1743R GFP-Nav1.5 channels. TP: Total Protein, IC: Intracellular, S: Surface. Note that values of S abundance were not directly quantitated from blots, but calculated as detailed in the method section. The presence of R878C significantly increases the cell surface expression of Kv4.3, * p = 0.033 consistent with the observed increase of Ito. Note: In cells co-expressing Nav1.5 and Kv4.3, the two channels were co-immunoprecipitated.
Figure 5. Nav1.5 and Kv4.3 interact with each other. (A): Co-immunoprecipitation between Nav1.5 and Kv4.3. HEK293 cells were transfected with WT or truncated Nav1.5 constructs and Kv4.3 (pcDNA3.1-GFP-SCN5A and pCMV-KCND3-Long-Flag) as indicated above the lanes. The total cell lysates were immunoprecipitated with an anti-Flag antibody, specific to Kv4.3-Flag, cross-linked to beads. The blots were hybridized with an anti-Nav1.5 antibody (top gels: Blot Ab: Nav1.5) or an anti-Flag antibody (bottom gels: Blot Ab: Flag). The left side corresponds to the total cell lysates of transfected cells before IP. The right side (IP with Flag Ab) corresponds to the elution fractions from beads. The negative control (center of panel A), consisting in an anti-Flag immunoprecipitation in lysates of cells expressing only GFP-Nav1.5 channels, clearly excluded any non-specific interaction between Nav1.5 and Kv4.3 channels. The results demonstrated an interaction between Kv4.3 and Nav1.5 (n = 7). (B): Duolink between GFP-Nav1.5 and Kv4.3-Flag. The top line corresponds to cells co-expressing GFP alone (pGFP) with Kv4.3-Flag while the bottom line cells co-expressing GFP-Nav1.5 with Kv4.3-Flag. Only cells expressing GFP-Nav1.5 and Kv4.3-Flag display red positive signals indicating a close proximity between the two channels. Note: Close proximity of the two channels can be observed within intracellular compartments. (C): Cell surface biotinylation of Kv4.3 in presence of WT, R878C or G1743R GFP-Nav1.5 channels. TP: Total Protein, IC: Intracellular, S: Surface. Note that values of S abundance were not directly quantitated from blots, but calculated as detailed in the method section. The presence of R878C significantly increases the cell surface expression of Kv4.3, * p = 0.033 consistent with the observed increase of Ito. Note: In cells co-expressing Nav1.5 and Kv4.3, the two channels were co-immunoprecipitated.
Ijms 21 05057 g005
Figure 6. Schematic of the influence of β-subunits of the two channels on the INa/Ito balance. Left panel represents raw traces of INa/Ito displaying a larger INa and smaller Ito as opposed to a smaller INa and larger Ito that could potentially lead to the expression of BrS. The right schematic shows a schematic of the influence of the β-subunits of the two channels on the INa/Ito balance.
Figure 6. Schematic of the influence of β-subunits of the two channels on the INa/Ito balance. Left panel represents raw traces of INa/Ito displaying a larger INa and smaller Ito as opposed to a smaller INa and larger Ito that could potentially lead to the expression of BrS. The right schematic shows a schematic of the influence of the β-subunits of the two channels on the INa/Ito balance.
Ijms 21 05057 g006
Table 1. Electrophysiological characteristics of Ito in presence of WT and loss of function (LOF) Nav1.5 channels.
Table 1. Electrophysiological characteristics of Ito in presence of WT and loss of function (LOF) Nav1.5 channels.
VariantnIto Peak +20 mVSEMFold ChangepnV1/2 SSI ItoSEMShiftpRelative Ito, HP at −40 mVSEMFold Change in Peak Ito, HP at −40 mV
WT5087.18.2NANA11−40.030.93NANA48.70.031
R878C14243.357.62.79<0.00114−39.741.20.29NS54.20.031.11
E555X15138.016.81.58<0.00118−41.650.37−1.62NS430.020.88
G1743R1854.812.90.63<0.00115−46.220.75−6.19<0.00132.90.020.68

Share and Cite

MDPI and ACS Style

Clatot, J.; Neyroud, N.; Cox, R.; Souil, C.; Huang, J.; Guicheney, P.; Antzelevitch, C. Inter-Regulation of Kv4.3 and Voltage-Gated Sodium Channels Underlies Predisposition to Cardiac and Neuronal Channelopathies. Int. J. Mol. Sci. 2020, 21, 5057. https://doi.org/10.3390/ijms21145057

AMA Style

Clatot J, Neyroud N, Cox R, Souil C, Huang J, Guicheney P, Antzelevitch C. Inter-Regulation of Kv4.3 and Voltage-Gated Sodium Channels Underlies Predisposition to Cardiac and Neuronal Channelopathies. International Journal of Molecular Sciences. 2020; 21(14):5057. https://doi.org/10.3390/ijms21145057

Chicago/Turabian Style

Clatot, Jérôme, Nathalie Neyroud, Robert Cox, Charlotte Souil, Jing Huang, Pascale Guicheney, and Charles Antzelevitch. 2020. "Inter-Regulation of Kv4.3 and Voltage-Gated Sodium Channels Underlies Predisposition to Cardiac and Neuronal Channelopathies" International Journal of Molecular Sciences 21, no. 14: 5057. https://doi.org/10.3390/ijms21145057

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop